Acro Biomedical (ACBM) Deferred Taxes (2018 - 2019)
Acro Biomedical's quarterly Deferred Taxes came in at -$73071.0 in Q3 2019, little changed quarter-over-quarter from -$73071.0 in Q2 2019.
Acro Biomedical has reported Deferred Taxes for 2 years, with the latest figure at -$73071.0 in Q3 2019.
- For the quarter ending Q3 2019, Deferred Taxes changed N/A year-over-year to -$73071.0; the trailing twelve-month figure through Sep 2020 stood at -$101018.0 (down 24.6% YoY), and the FY2019 full-year result was -$19941.0, changed N/A from the prior year.
- Deferred Taxes for Q3 2019 stood at -$73071.0, roughly flat from -$73071.0 in the prior quarter.
- The five-year high for Deferred Taxes was $45124.0 in Q1 2019, with the low at -$73071.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | - |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | - |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | - |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | - |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | - |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | - |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | - |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | - |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | - |
| 10 | Acro Biomedical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -73,071.00 |
| Jun 30, 2019 | -73,071.00 |
| Mar 31, 2019 | 45,124.00 |
| Dec 31, 2018 | 19,941.00 |